Clinical Trial Update: The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients. [NA]

View source ↗

Summary

This clinical trial update reports on the efficacy and safety of ZS802 for Hemophilia A in Chinese patients; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• ZS802

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Hemophilia A | NA | Status: RECRUITING